Rankings
▼
Calendar
NERV Q3 2016 Earnings — Minerva Neurosciences, Inc. Revenue & Financial Results | Market Cap Arena
NERV
Minerva Neurosciences, Inc.
$52M
Q3 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$8M
Net Income
-$8M
EPS (Diluted)
$-1.94
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$935,453
Balance Sheet
Total Assets
$142M
Total Liabilities
$29M
Stockholders' Equity
$113M
Cash & Equivalents
$92M
← FY 2016
All Quarters
Q4 2016 →